Pages that link to "Q78505626"

The following pages link to Systemic endotoxemia during chronic viral hepatitis (Q78505626):

Displaying 15 items.

• Microbial translocation in chronic liver diseases (Q21284997) (← links)
• Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure (Q34490057) (← links)
• Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients. (Q35191924) (← links)
• Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats (Q36357435) (← links)
• Cisplatin protects against acute liver failure by inhibiting nuclear HMGB1 release (Q37007136) (← links)
• Toll-like receptors as targets in chronic liver diseases (Q37469924) (← links)
• Gut microbiota and probiotics in chronic liver diseases (Q37821601) (← links)
• The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. (Q37834316) (← links)
• Inhibitions of NF-κB and TNF-α result in differential effects in rats with acute on chronic liver failure induced by d-Gal and LPS. (Q39037784) (← links)
• Probiotic as a novel treatment strategy against liver disease (Q39974040) (← links)
• Sodium butyrate protects against toxin-induced acute liver failure in rats. (Q42210945) (← links)
• Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. (Q42231930) (← links)
• Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats. (Q42266454) (← links)
• Long noncoding RNA hypoxia-inducible factor 1 alpha-antisense RNA 1 promotes tumor necrosis factor-α-induced apoptosis through caspase 3 in Kupffer cells (Q49215876) (← links)
• On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B. (Q54202324) (← links)